Covaxin effective against UK Strain: What does this mean in absence of efficacy data?
Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts
Is SARS-CoV-2 becoming more stable? A new study tracks virus’ evolution
The virus also showed signs of stabilising around some proteins, according to the study
Need to ramp up vaccine supply for developing countries: Global task force on COVID-19
Heads of the World Bank Group, International Monetary Fund, World Health Organization and World Trade Organization met for the first time …
COVID-19: Trials for cure at a glance
Scientists across the globe are working to develop vaccines for the novel coronavirus disease while exploring whether existing drugs can be …
First 2 phases of Russian vaccine trial indicate safety and efficacy: Study
Two formulations of the vaccine have been developed: One could be introduced through global supply chain and other in hard-to-reach regions
Kerala HC directs NDMA to formulate compensation policy for those dying due to COVID-19 vaccine
The order was passed September 1 and a time frame of three months has been set; the move sets a precedent since no such policy has been …
A vaccine only for Omicron: Does India really need it?
Experts bat for considering benefits, economics carefully before spending on bivalent shots
Gujarat recipients gung-ho on COVID-19 vaccine
The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round
West Bengal rolls out COVID-19 vaccines even as politics creeps in
Political parties blame each other of ‘vaccine theft’ in the poll-bound state
COVID-19 immunity: how long does it last?
In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic
Why COVID-19 will not kill off global business travel
In medium term, life sciences companies will continue to expand and view travel as a vital channel for maintaining new business in markets
No COVID-19 vaccine before 2021, Centre puts out then deletes
Sentence in question inadvertently included: PIB official; Things are contextual, says author of original article
COVID-19: Phase 3 of vaccine developed by Chinese researchers underway, says Lancet
The Ad5-vectored COVID-19 vaccine tested on people above 55 years of age, is considered a step up from another vaccine being developed by the UK
COVID-19 vaccine: Oxford-AstraZeneca up to 90% effective in late stage trial
Adenovirus vaccine can be stored at 2-8°C; company to apply for emergency authorisation
India should not prefer Russian COVID-19 vaccine over own: Vaccinologist Peter Hotez
India has a golden chance to emerge as a superpower; vaccine dissemination would be a paramount challenge, Hotez says in an …
Wealthy nations starved the developing world of vaccines. Omicron shows the cost of this greed
10 high-income countries will be sitting on more than 870 million excess doses by end of 2021
COVID-19: What will be a fair policy to distribute vaccine
No country is safe if only its own citizens are inoculated; the question of equitable distribution of a vaccine is as much a global concern as it …
Ramdev shouldn’t criticise other systems of medicine: SC
Reply sought from Patanjali, Centre over Indian Medical Association plea; Experts say time to update Ayurveda textbooks
COVID-19: Vaccine inequity persists as 2.8 billion people yet to receive even one dose
Low-income countries will also have to spend more to achieve 70% vaccination target
COVID-19 update: India overtakes Brazil as 2nd worst-hit country
A few government and private hospitals will again be converted into fully COVID-19 facilities, said Delhi CM Arvind Kejriwal
Lateral Thoughts: We have neglected vaccines for neglected diseases
Vaccines against COVID-19 prove without doubt that the ones needed to prevent neglected disease can be developed quickly as well
Drug Controller General dodges query on COVID-19 vaccine adverse event
Govt webinar on clinical trials also skips questions on emergency authorisation, expert committees
Air pollution linked to 15% global COVID-19 deaths: Study
Contributed to 27% COVID-19 deaths in East Asia; 19% in Europe, 17% in North America
What COVID-19 vaccine side effects might I expect?
In the vast majority of cases, any side effect you feel will be over within a few days, and there is no reason for concern
COVID-19 vaccine: WTO chief brushes aside TRIPS waiver
Ngozi Okonjo-Iweala offers ‘third way’ to bridge the COVID vaccine shortfall based on more licensing agreements